Literature DB >> 22762893

Thrombin generation: what have we learned?

Raed Al Dieri1, Bas de Laat, H Coenraad Hemker.   

Abstract

Thrombin is a pivotal player in the coagulation system. In clotting blood a transient wave of thrombin appears after a lag time. Clotting occurs at the start of the wave. The amount of thrombin formed reflects the function of the hemostatic system much better than the clotting time does: "The more thrombin the less bleeding but the more thrombosis, the less thrombin the more bleeding but the less thrombosis" has been shown to hold for congenital and acquired tendencies to venous thrombosis and bleeding and under all variants of antithrombotic treatment. The situation with arterial thrombosis is less clear. Calibrated automated thrombinography (CAT) allows quantitative assessment of the thrombin generation (TG) curve in platelet poor as well as in platelet rich plasma. Procedures to measure TG in whole blood and at the point of care are under development. TG measurement in platelet rich plasma underlines the close cooperation between platelets and the clotting system and challenges the traditional division between primary and secondary hemostases.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22762893     DOI: 10.1016/j.blre.2012.06.001

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  39 in total

1.  Warfarin dose requirement in patients having severe thrombosis or thrombophilia.

Authors:  Tuukka A Helin; Lotta Joutsi-Korhonen; Heidi Asmundela; Mikko Niemi; Arto Orpana; Riitta Lassila
Journal:  Br J Clin Pharmacol       Date:  2019-06-17       Impact factor: 4.335

Review 2.  Platelets: at the nexus of antimicrobial defence.

Authors:  Michael R Yeaman
Journal:  Nat Rev Microbiol       Date:  2014-06       Impact factor: 60.633

3.  Platelets Mediate Host Defense against Staphylococcus aureus through Direct Bactericidal Activity and by Enhancing Macrophage Activities.

Authors:  Ramadan A Ali; Leah M Wuescher; Keith R Dona; Randall G Worth
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

4.  Platelets: essential components of the immune system.

Authors:  Ramadan A Ali; Leah M Wuescher; Randall G Worth
Journal:  Curr Trends Immunol       Date:  2015

5.  Increased BMI and Blood Lipids Are Associated With a Hypercoagulable State in the Moli-sani Cohort.

Authors:  Romy de Laat-Kremers; Augusto Di Castelnuovo; Lisa van der Vorm; Simona Costanzo; Marisa Ninivaggi; Chiara Cerletti; Dana Huskens; Amalia De Curtis; Alessandro Gialluisi; Cuicui Bai; Giovanni de Gaetano; Dongmei Yin; Maria Benedetta Donati; Bas de Laat; Licia Iacoviello
Journal:  Front Cardiovasc Med       Date:  2022-06-16

6.  Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin.

Authors:  Romy M W Kremers; Stéphane Zuily; Hilde Kelchtermans; Tessa C Peters; Saartje Bloemen; Véronique Regnault; H Coenraad Hemker; Philip G de Groot; Denis Wahl; Bas de Laat
Journal:  Blood Adv       Date:  2018-06-12

Review 7.  Why factor XI deficiency is a clinical concern.

Authors:  Allison P Wheeler; David Gailani
Journal:  Expert Rev Hematol       Date:  2016-06-24       Impact factor: 2.929

8.  Follow-up of thrombin generation after prostate cancer surgery: global test for increased hypercoagulability.

Authors:  Matyas Benyo; Tibor Flasko; Zsuzsanna Molnar; Adrienne Kerenyi; Zoltan Batta; Tamas Jozsa; Jolan Harsfalvi
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

Review 9.  A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis.

Authors:  Marcus D Lancé
Journal:  Thromb J       Date:  2015-01-12

10.  Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy.

Authors:  C P D M de Breet; S Zwaveling; M J A Vries; R G van Oerle; Y M C Henskens; A W J Van't Hof; P E J van der Meijden; L Veenstra; H Ten Cate; R H Olie
Journal:  Front Cardiovasc Med       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.